Journal ArticleOPEN ACCESS

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models

  • Huseni M
  • Totpal K
  • Du C
  • et al.
Journal for ImmunoTherapy of Cancer (2014) 2(S3)
DOI: 10.1186/2051-1426-2-s3-p105
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Huseni, M., Totpal, K., Du, C., Dalpozzo, K., Zhu, J., Rishipathak, D., … Kim, J. (2014). Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models. Journal for ImmunoTherapy of Cancer, 2(S3). https://doi.org/10.1186/2051-1426-2-s3-p105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free